HLB Therapeutics Co Ltd banner
H

HLB Therapeutics Co Ltd
KOSDAQ:115450

Watchlist Manager
HLB Therapeutics Co Ltd
KOSDAQ:115450
Watchlist
Price: 3 485 KRW -0.43% Market Closed
Market Cap: ₩308.7B

HLB Therapeutics Co Ltd
Total Other Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

HLB Therapeutics Co Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
H
HLB Therapeutics Co Ltd
KOSDAQ:115450
Total Other Income
-₩44.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
24%
Celltrion Inc
KRX:068270
Total Other Income
-₩101.7B
CAGR 3-Years
-91%
CAGR 5-Years
-112%
CAGR 10-Years
-110%
O
OliX Pharmaceuticals Inc
KOSDAQ:226950
Total Other Income
₩78.6m
CAGR 3-Years
5%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Total Other Income
-₩65.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Other Income
₩14B
CAGR 3-Years
67%
CAGR 5-Years
114%
CAGR 10-Years
133%
A
ABL Bio Inc
KOSDAQ:298380
Total Other Income
-₩453.1m
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

HLB Therapeutics Co Ltd
Glance View

Market Cap
308.7B KRW
Industry
Biotechnology

HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2010-03-26. Along with its affiliates, the Company operates solution business segment, which provides embedded graphic user interface (GUI) software solutions as well as wired and wireless integration multimedia platform solutions. Its embedded GUI products include FXUI-two-dimensional (2D), FXUI-three-dimensional (3D) and FX Studio, which are used for cellular phones and embedded equipment. Its wired and wireless integration multimedia platform products include FX-Flash and others, which are used for cellular phones and other mobile devices; electronic components manufacturing business segment, which provides transformers, pumps, motors and others, as well as educational and bio pharmaceutical business segments.

Intrinsic Value
2 349.96 KRW
Overvaluation 33%
Intrinsic Value
Price ₩3 485
H

See Also

What is HLB Therapeutics Co Ltd's Total Other Income?
Total Other Income
-44.3m KRW

Based on the financial report for Dec 31, 2025, HLB Therapeutics Co Ltd's Total Other Income amounts to -44.3m KRW.

What is HLB Therapeutics Co Ltd's Total Other Income growth rate?
Total Other Income CAGR 10Y
24%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett